Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 12 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E143.36 EPS (ttm)0.06 Insider Own7.65% Shs Outstand34.25M Perf Week9.61%
Market Cap245.59M Forward P/E12.33 EPS next Y0.66 Insider Trans-0.49% Shs Float28.00M Perf Month30.23%
Income8.05M PEG- EPS next Q0.09 Inst Own53.51% Short Float3.84% Perf Quarter35.23%
Sales187.32M P/S1.31 EPS this Y107.69% Inst Trans8.06% Short Ratio5.19 Perf Half Y74.19%
Book/sh-1.04 P/B- EPS next Y143.21% ROA5.77% Short Interest1.07M Perf Year15.06%
Cash/sh2.60 P/C3.12 EPS next 5Y- ROE- 52W Range3.65 - 8.22 Perf YTD63.97%
Dividend Est.- P/FCF12.12 EPS past 5Y-19.96% ROI11.21% 52W High-1.46% Beta0.99
Dividend TTM- Quick Ratio3.76 Sales past 5Y14.07% Gross Margin67.66% 52W Low121.69% ATR (14)0.34
Dividend Ex-Date- Current Ratio4.75 EPS Y/Y TTM130.88% Oper. Margin19.09% RSI (14)72.76 Volatility4.16% 5.28%
Employees194 Debt/Eq- Sales Y/Y TTM8.49% Profit Margin4.30% Recom1.00 Target Price9.27
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q84.55% Payout0.00% Rel Volume1.93 Prev Close8.00
Sales Surprise2.46% EPS Surprise-220.00% Sales Q/Q4.37% EarningsMay 07 AMC Avg Volume207.00K Price8.10
SMA2012.12% SMA5023.07% SMA20046.40% Trades Volume400,133 Change1.25%
Date Action Analyst Rating Change Price Target Change
Feb-20-24Initiated B. Riley Securities Buy $9
Feb-01-24Initiated Jefferies Buy
Jun-24-22Initiated Cowen Outperform $11
Jun-23-22Initiated ROTH Capital Buy $9
Jul-09-24 09:55AM
Jun-24-24 03:27AM
Jun-20-24 04:45PM
May-20-24 10:08AM
May-09-24 11:14AM
06:48AM Loading…
May-08-24 06:48AM
May-07-24 09:56PM
Apr-30-24 10:00AM
Apr-29-24 04:05PM
Apr-23-24 04:05PM
Mar-13-24 08:37AM
Mar-12-24 06:11PM
04:05PM Loading…
Mar-05-24 10:00AM
Feb-27-24 04:05PM
Feb-20-24 04:05PM
Jan-25-24 04:05PM
Jan-17-24 04:05PM
Jan-11-24 04:05PM
Nov-07-23 08:25PM
Oct-24-23 08:30AM
Aug-10-23 06:40PM
Jul-27-23 08:30AM
Jul-13-23 09:29AM
07:00AM Loading…
Jun-22-23 07:00AM
Jun-08-23 06:05PM
Jun-05-23 07:48AM
May-31-23 08:30AM
May-30-23 08:30AM
May-09-23 05:21PM
Apr-26-23 08:30AM
Apr-10-23 08:30AM
Mar-31-23 09:55AM
Mar-28-23 04:15PM
Mar-27-23 09:00AM
Mar-02-23 08:00AM
Feb-09-23 04:15PM
Jan-09-23 05:30PM
Jan-05-23 06:00AM
Nov-10-22 08:30AM
Nov-08-22 04:15PM
Nov-07-22 09:15AM
Oct-31-22 08:30AM
Oct-10-22 07:45AM
Sep-07-22 08:30AM
Aug-25-22 04:05PM
Aug-24-22 08:30AM
Aug-15-22 04:56PM
Aug-09-22 04:15PM
Jul-20-22 11:00AM
Jul-18-22 10:24AM
Jun-16-22 08:30AM
Jun-06-22 04:05PM
Jun-03-22 08:59AM
May-26-22 04:05PM
biote Corp. is a woman-led company, which engages in providing bio identical hormone pellet therapy. It delivers a comprehensive, end-to-end platform that provides practitioners with medical education, training and certification, practice management software, and digital and point-of-care marketing support. The company is headquartered in Irving, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Peterson Robert CharlesChief Financial OfficerJul 09 '24Sale7.5711,37686,08432,874Jul 10 04:31 PM
Peterson Robert CharlesChief Financial OfficerJul 08 '24Option Exercise0.0044,250044,250Jul 10 04:31 PM